(954) 509-0911
(877)
895-5647
Due to SEC Regulation Fair Disclosure, we cannot communicate individually with shareholders. For answers to basic shareholder questions pertaining to the location of historical factual information contained within the Company’s past press releases and/or the Company’s website, you may email investor.relations@nutrapharma.com.
Please note: We cannot address any questions pertaining to corporate financial information, including, but not limited to, past, present or future stock performance. |